HOME >> BIOLOGY >> NEWS
FDA finds no strong link between tomatoes and reduced cancer risk

A U.S. Food and Drug Administration (FDA) review has found only limited evidence for an association between eating tomatoes and a decreased risk of certain cancers, according to an article published online July 10 in the Journal of the National Cancer Institute.

Several studies have reported an association between the consumption of tomatoes or lycopene, an antioxidant that gives tomatoes their red hue, and a decreased risk of some cancers, particularly prostate cancer. In order for foods and dietary supplements to be labeled with such health claims, the FDA must review and approve these claims based on the available scientific evidence.

In a review article, Claudine Kavanaugh, Ph.D., of the FDA in College Park, Md., and colleagues describe the agencys November 2005 evaluation of the scientific evidence linking tomatoes or tomato-based foods, lycopene, and reduced cancer risk.

Their review found no evidence that tomatoes reduced the risk of lung, colorectal, breast, cervical, or endometrial cancer. However, there was very limited evidence for associations between tomato consumption and reduced risk of prostate, ovarian, gastric, and pancreatic cancers. Based on this assessment, the FDA decided to allow qualified health claims for a very limited association between tomatoes and these four cancers. Their analysis found no credible evidence that lycopene, either in food or in a dietary supplement, was associated with reduced risk of any of the cancers evaluated.

For prostate cancer, for example, the FDA issued this statement: Very limited and preliminary scientific research suggests that eating one-half to one cup of tomatoes and/or tomato sauce a week may reduce the risk of prostate cancer. [The] FDA concludes that there is little scientific evidence supporting this claim.

In one of the accompanying editorials, Paul Coates, Ph.D., of the National Institutes of Health in Bethesda, Md., discusses some of th
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
10-Jul-2007


Page: 1 2

Related biology news :

1. Pollution causes 40 percent of deaths worldwide, study finds
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. In limiting life span, study finds booming bacteria innocent
4. AAAS analysis finds Congress would add billions to FY 2008 R&D investment
5. Genetic analysis finds greater threat in frog-killing fungus
6. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
7. Study finds contaminated water reaching Floridas offshore keys
8. Bumblebees make bee line for gardens, National Bumblebee Nest Survey finds
9. Study finds hereditary link to premenstrual depression
10. Longest study finds reef fish need longer break
11. Illinois-based study of energy crops finds miscanthus more productive than switchgrass

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/9/2019)... ... April 09, 2019 , ... The McLeod Center for ... following a rigorous and voluntary audit conducted by an independent, third-party panel of ... Novalis Certified Centers in the United States, McLeod is the only such cancer center ...
(Date:4/4/2019)... , ... April 02, 2019 , ... ... commercialization of first-in-class stromal cell immunotherapies, announced it will move its base of ... anchor tenant at the University’s newly created biotechnology park in Galway, Ireland. , ...
(Date:4/4/2019)... ... April 03, 2019 , ... R3 Stem Cell is now ... Centers of Excellence. R3 wants patients to feel secure when they make a ... from Centers that use inferior regenerative biologics, protocols or amounts, R3 provides a ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... ... hospital in Israel and the Middle East region, and Swiss-based CDMO Lonza ... manufacturing platform. The partnership will enable Sheba to vastly streamline its in-house ...
(Date:3/18/2019)... ... March 18, 2019 , ... For more than 15 years, ... solutions that allow life science companies to easily comply with FDA 21 CFR Part ... ™ is a managed service delivering end-to-end GxP compliance from vendor audit through ongoing ...
(Date:3/14/2019)... ... March 14, 2019 , ... EyeCRO LLC ... City, OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma Medical Research ... the fifth institution in Oklahoma to receive this prestigious endorsement. The award ...
(Date:3/14/2019)... ... March 14, 2019 , ... Open registration for ... the Full Spectrum of Case Management,” continues as CMSA makes plans to host ... the only case management industry conference serving the educational and networking needs of ...
Breaking Biology Technology:
Cached News: